Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$0.28 - $1.16 $12,393 - $51,342
-44,261 Reduced 32.77%
90,796 $29,000
Q1 2024

Apr 22, 2024

BUY
$1.06 - $1.67 $12,995 - $20,474
12,260 Added 9.98%
135,057 $156,000
Q4 2023

Jan 16, 2024

SELL
$1.26 - $1.79 $1,418 - $2,015
-1,126 Reduced 0.91%
122,797 $207,000
Q3 2023

Oct 24, 2023

BUY
$1.61 - $2.54 $81,102 - $127,949
50,374 Added 68.49%
123,923 $224,000
Q2 2023

Jul 25, 2023

BUY
$1.14 - $1.95 $1,569 - $2,685
1,377 Added 1.91%
73,549 $136,000
Q1 2023

Apr 14, 2023

SELL
$1.2 - $2.19 $12,758 - $23,284
-10,632 Reduced 12.84%
72,172 $95,000
Q4 2022

Feb 08, 2023

SELL
$1.63 - $3.52 $137,728 - $297,425
-84,496 Reduced 50.51%
82,804 $139,000
Q3 2022

Oct 25, 2022

BUY
$0.73 - $3.74 $97,918 - $501,664
134,135 Added 404.45%
167,300 $522,000
Q2 2022

Aug 12, 2022

BUY
$2.2 - $4.2 $15,558 - $29,702
7,072 Added 27.1%
33,165 $79,000
Q1 2022

May 11, 2022

BUY
$2.83 - $8.69 $39,498 - $121,286
13,957 Added 115.0%
26,093 $105,000
Q4 2021

Feb 08, 2022

SELL
$8.31 - $14.92 $44,383 - $79,687
-5,341 Reduced 30.56%
12,136 $101,000
Q3 2021

Nov 02, 2021

BUY
$9.15 - $13.28 $159,914 - $232,094
17,477 New
17,477 $203,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $8.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.